Eman Ahmed

This name is associated with a highly varied publication record spanning medicinal chemistry (synthesis of pyridazine and triazolopyridazine compounds as anti-inflammatory and anticancer agents), materials science (nanocomposites, 2D materials for solar cells), and unrelated fields like networking, dermatology, and education research. Core chemistry work focuses on designing and testing new small molecules that inhibit inflammation-related enzymes (like COX-2) or cancer-related targets (like CDK-4 and c-Met/Pim-1 kinases), often combined with computational docking studies to predict how these molecules bind to their targets. Because the publication list covers such disparate topics and venues, it likely reflects contributions from multiple collaborations or possibly multiple individuals sharing this name.

Publication output has grown substantially over the last decade, rising from just 1 paper per year in 2017-2018 to a sustained pace of 12-18 papers per year between 2021 and 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026